The intersection of pregnancy health, viral infections, and medication safety has never been more pressing. As new concerns emerge about COVID-19 risks during pregnancy, debates over ivermectin resurface, sparking nationwide policy reviews, medical studies, and calls for transparency. The issue goes beyond pandemic-era controversies: it reflects broader questions about how the U.S. healthcare...